10-K
XBRL
ANNUAL REPORT
- Company
- Edesa Biotech, Inc.
- Filed
- December 28, 2021
- Period of Report
- September 30, 2021
- Accession Number
- 0001654954-21-013551
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →